1 study found for:    22343727 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Biological: rituximab;   Drug: ABVD regimen;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Genetic: DNA methylation analysis;   Other: laboratory biomarker analysis;   Radiation: fludeoxyglucose F 18

Indicates status has not been verified in more than two years